Trial Profile
Clinical Trial to Evaluate the Safety and Immunogenicity in Age De-Escalation of Direct Venous Inoculation of a Plasmodium Falciparum Sporozoite Vaccine in Tanzanian Adults, Children, and Infants
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Malaria vaccine live attenuated-Sanaria (Primary)
- Indications Malaria
- Focus Adverse reactions
- Sponsors Sanaria
- 29 Nov 2019 Results published in the Clinical Infectious Diseases
- 13 Dec 2017 Status changed from active, no longer recruiting to completed.
- 24 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 Jun 2017.